Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer.
Antibodies (Basel)
; 5(1)2016 Mar 04.
Article
in En
| MEDLINE
| ID: mdl-31557987
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Antibodies (Basel)
Year:
2016
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Suiza